Acer Therapeutics Inc (ACER)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2008 | 06-2008 | 03-2008 | 12-2007 | 09-2007 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 4,044 | 3,494 | 6,326 | 2,646 | 5,840 |
| Other current assets | 180 | 364 | 176 | 355 | 390 |
| TOTAL | $4,224 | $3,857 | $6,502 | $3,001 | $6,230 |
| Non-Current Assets | |||||
| PPE Net | 1,226 | 1,285 | 1,321 | 1,371 | 1,880 |
| Other Non-Current Assets | 0 | 0 | 0 | 0 | 22,340 |
| TOTAL | $1,226 | $1,285 | $1,321 | $1,371 | $24,220 |
| Total Assets | $5,450 | $5,142 | $7,824 | $4,371 | $29,930 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 64 | 63 | 62 | 60 | 0 |
| Accounts payable and accrued liabilities | 954 | 842 | 873 | 993 | 1,220 |
| Accrued Expenses | 1,051 | 880 | 929 | 1,023 | 790 |
| TOTAL | $2,069 | $1,784 | $1,863 | $2,075 | $2,070 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | N/A | 170 |
| Other Non-Current Liabilities | 116 | 132 | 147 | 163 | 0 |
| TOTAL | $116 | $132 | $147 | $163 | $170 |
| Total Liabilities | $2,185 | $1,916 | $2,010 | $2,238 | $2,250 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 37 | 37 | 31 | N/A | N/A |
| Common Shares | 6,132 | 5,130 | 5,098 | 3,348 | 3,340 |
| Retained earnings | -87,580 | -84,450 | -80,815 | -77,713 | -51,530 |
| TOTAL | $3,265 | $3,226 | $5,814 | $2,134 | $27,670 |
| Total Liabilities And Equity | $5,450 | $5,142 | $7,824 | $4,371 | $29,920 |